Literature DB >> 18558292

Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome.

E C B da Costa1, F R Vargas, A S Moreira, J J Lourenço, M Caleffi, P Ashton-Prolla, M A M Martins Moreira.   

Abstract

The 5382insC mutation in BRCA1 is a frequently reported mutation, being very prevalent in Central and Eastern Europe. This mutation was recurrently reported in Brazil and one case was reported Portugal, but not in Spain and other South-American countries,. We analyzed the haplotypic profile of seven Brazilian carriers of 5382insC to characterize a possible founder effect. The analyses indicated that mutation carriers shared an identical haplotype. The absence of this mutation in Spain, other South American countries, and sub-Saharan populations, as well as the patients' own ancestry, point to a significant Central or Eastern European contribution to the present genetic background of Brazilian population, different from the population structuring of remaining South American countries.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18558292     DOI: 10.1016/j.cancergencyto.2008.03.011

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  14 in total

Review 1.  Mutations in context: implications of BRCA testing in diverse populations.

Authors:  Gabriela E S Felix; Yonglan Zheng; Olufunmilayo I Olopade
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

Review 2.  Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.

Authors:  Carlos Andrés Ossa; Diana Torres
Journal:  Oncologist       Date:  2016-06-10

3.  Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome.

Authors:  Ingrid P Ewald; Patrícia Izetti; Fernando R Vargas; Miguel Am Moreira; Aline S Moreira; Carlos A Moreira-Filho; Danielle R Cunha; Sara Hamaguchi; Suzi A Camey; Aishameriane Schmidt; Maira Caleffi; Patrícia Koehler-Santos; Roberto Giugliani; Patricia Ashton-Prolla
Journal:  Hered Cancer Clin Pract       Date:  2011-12-20       Impact factor: 2.857

4.  Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.

Authors:  Wijden Mahfoudh; Noureddine Bouaouina; Slim Ben Ahmed; Sallouha Gabbouj; Jingxuan Shan; Rebecca Mathew; Nancy Uhrhammer; Yves-Jean Bignon; Wafa Troudi; Amel Ben Ammar Elgaaied; Elham Hassen; Lotfi Chouchane
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

5.  Prevalence and impact of founder mutations in hereditary breast cancer in Latin America.

Authors:  Patricia Ashton-Prolla; Fernando Regla Vargas
Journal:  Genet Mol Biol       Date:  2014-03       Impact factor: 1.771

6.  Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.

Authors:  Patricia Ashton-Prolla; Juliana Giacomazzi; Aishameriane V Schmidt; Fernanda L Roth; Edenir I Palmero; Luciane Kalakun; Ernestina S Aguiar; Susana M Moreira; Erica Batassini; Vanessa Belo-Reyes; Lavinia Schuler-Faccini; Roberto Giugliani; Maira Caleffi; Suzi Alves Camey
Journal:  BMC Cancer       Date:  2009-08-14       Impact factor: 4.430

7.  Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.

Authors:  S Armaou; M Pertesi; F Fostira; G Thodi; P S Athanasopoulos; S Kamakari; A Athanasiou; H Gogas; D Yannoukakos; G Fountzilas; I Konstantopoulou
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

8.  Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.

Authors:  Dirce Maria Carraro; Maria Aparecida Azevedo Koike Folgueira; Bianca Cristina Garcia Lisboa; Eloisa Helena Ribeiro Olivieri; Ana Cristina Vitorino Krepischi; Alex Fiorini de Carvalho; Louise Danielle de Carvalho Mota; Renato David Puga; Maria do Socorro Maciel; Rodrigo Augusto Depieri Michelli; Eduardo Carneiro de Lyra; Stana Helena Giorgi Grosso; Fernando Augusto Soares; Maria Isabel Alves de Souza Waddington Achatz; Helena Brentani; Carlos Alberto Moreira-Filho; Maria Mitzi Brentani
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

9.  Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.

Authors:  Ramūnas Janavičius
Journal:  EPMA J       Date:  2010-06-27       Impact factor: 6.543

10.  Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.

Authors:  Felipe C Silva; Bianca Cg Lisboa; Marcia Cp Figueiredo; Giovana T Torrezan; Erika Mm Santos; Ana C Krepischi; Benedito M Rossi; Maria I Achatz; Dirce M Carraro
Journal:  BMC Med Genet       Date:  2014-05-15       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.